Holen Sie sich die Stockscreener-App
33.81
2.54%
-0.88
Handel nachbörslich:
31.96
-1.85
-5.47%
Vor Biopharma Inc Aktie (VOR) Neueste Nachrichten
Vor Biopharma: Transformed Company Is A High Risk Buy On Autoimmune Disease Promise - Seeking Alpha
Vor Biopharma Shares Slide Following Warrant Registration Filing - MSN
Vor Biopharma stock drops after filing to register warrant shares By Investing.com - Investing.com Nigeria
Vor Biopharma stock drops after filing to register warrant shares - Investing.com
Stifel upgrades Vor Biopharma stock to Buy on telitacicept prospects By Investing.com - Investing.com South Africa
Vor Biopharma (VOR) Registers 51M Shares for Resale, Warrants in Focus - GuruFocus
Vor Biopharma files for offering of up to 51 million common shares by the selling stockholdersSEC filing - MarketScreener
Vor Biopharma (VOR) files for 51M share offering by selling stockholders - StreetInsider
Vor Biopharma upgraded to Buy at Stifel on telitacicept prospects - Seeking Alpha
Stifel upgrades Vor Biopharma stock to Buy on telitacicept prospects - Investing.com India
Stifel Nicolaus Upgrades Vor Biopharma (NYSE:VOR) to Buy - MarketBeat
Vor Biopharma climbs after Stifel upgrades rating on autoimmune drug potential - TradingView
Vor Biopharma (NYSE:VOR) Stock Price Down 8.6% Following Insider Selling - MarketBeat
Vor Biopharma’s Strategic Moves and Telitacicept’s Potential Drive Buy Rating Amid Stock Decline - TipRanks
Vor Bio appoints Navid Khan as chief medical affairs officer By Investing.com - Investing.com South Africa
Vor Bio appoints Navid Khan as chief medical affairs officer - Investing.com
Vor Biopharma (VOR) Sees Significant Increase in Borrow Rate - GuruFocus
Vor Bio Appoints Navid Z. Khan, Ph.D., as Chief Medical Affairs Officer - GlobeNewswire
7 Successful Drug Launches: Vor Bio Taps VYVGART Launch Veteran Navid Khan as Medical Affairs Chief - Stock Titan
Vor Biopharma (NASDAQ:VOR) Shares Down 7.2%What's Next? - MarketBeat
Vor Biopharma (NYSE:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 22,363 Shares - MarketBeat
Analysts Set Vor Biopharma Inc. (NYSE:VOR) Price Target at $6.07 - MarketBeat
Street Watch: Is Vor Biopharma Inc stock overvalued or fairly pricedTrade Entry Summary & Proven Capital Preservation Tips - خودرو بانک
Vor Biopharma (NYSE:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 447,278 Shares - MarketBeat
Insider Selling: Vor Biopharma (NYSE:VOR) Major Shareholder Sells 20,000 Shares of Stock - MarketBeat
Momentum Shift: What is the PEG ratio of Vor Biopharma IncQuarterly Trade Report & Entry Point Confirmation Signals - خودرو بانک
Insider Selling: Vor Biopharma (NYSE:VOR) Major Shareholder Sells 14,240 Shares of Stock - MarketBeat
Risk Report: Is Vor Biopharma Inc. part of any ETF2025 Price Action Summary & Verified Swing Trading Watchlists - khodrobank.com
Reprogrammed Interchange Llc Sells 300,000 Shares of Vor Biopharma (NYSE:VOR) Stock - MarketBeat
Vor Biopharma Inc. recovery potential after sell offInflation Watch & Weekly Stock Performance Updates - newser.com
How to interpret RSI for Vor Biopharma Inc. stockMarket Performance Summary & Verified Technical Signals - newser.com
Will Vor Biopharma Inc. rebound enough to break evenPortfolio Profit Report & Fast Moving Stock Watchlists - newser.com
Vor Biopharma ten percent owner sells $688k in shares By Investing.com - Investing.com Australia
Vor Biopharma (VOR) Faces Trading Halt Amid Reverse Stock Split and Share Sale - GuruFocus
Vor Biopharma trading halted on Thursday, news pending (VOR:NASDAQ) - Seeking Alpha
Relative strength of Vor Biopharma Inc. in sector analysis2025 Momentum Check & Real-Time Chart Pattern Alerts - newser.com
Will Vor Biopharma Inc. bounce back from current supportWeekly Investment Report & Weekly Watchlist for Hot Stocks - newser.com
What momentum shifts mean for Vor Biopharma Inc.Market Activity Report & Reliable Entry Point Trade Alerts - newser.com
What’s the recovery path for long term holders of Vor Biopharma Inc.July 2025 Pullbacks & Low Risk High Reward Ideas - newser.com
Vor Biopharma ten percent owner sells $688k in shares - Investing.com
Using Bollinger Bands to evaluate Vor Biopharma Inc.Portfolio Gains Summary & Community Consensus Picks - newser.com
Gains Report: Is Vor Biopharma Inc stock overvalued or fairly pricedWeekly Trend Report & AI Driven Price Predictions - khodrobank.com
Vor Biopharma Announces 1-for-20 Reverse Stock Split - TipRanks
Vor Biopharma (NASDAQ:VOR) Rating Increased to Hold at Zacks Research - MarketBeat
Vor Bio Announces Oral Presentation of 48-Week China Phase - GlobeNewswire
Vor Biopharma announces 1-for-20 reverse stock split effective Thursday - Investing.com India
Weekly Recap: How cyclical is Vor Biopharma Inc.’s revenue stream2025 Market Outlook & High Win Rate Trade Tips - khodrobank.com
CEO Moves: Can Vor Biopharma Inc keep up with sector leadersJuly 2025 Highlights & Daily Market Momentum Tracking - خودرو بانک
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):